Literature DB >> 22261293

Selection algorithm for posterior versus lateral approach in laparoscopic adrenalectomy.

Orhan Agcaoglu1, Dursun Ali Sahin, Allan Siperstein, Eren Berber.   

Abstract

BACKGROUND: There are no objective selection criteria described in the literature for the laparoscopic posterior retroperitoneal (PR) versus lateral transabdominal (LT) approach in a given patient. The aim of this study is to quantify the algorithm we have been using in our practice.
METHODS: Within 11 years, 219 patients underwent laparoscopic adrenalectomy at one institution. The laparoscopic LT technique was used in patients with unilateral tumors >6 cm. In those patients with unilateral tumors <6 cm, anthropometric parameters were used to select between laparoscopic PR and LT approaches. These parameters were quantified for 82 patients from computed tomography scans and their effects on operative time were calculated. Statistical analyses were performed by use of the t test and logistic regression analysis.
RESULTS: Fifty-two patients underwent laparoscopic LT and 30 patients underwent PR adrenalectomy. Patients were selected for the PR approach if the distance from Gerota's fascia to the skin was less than 5 cm and the 12th rib was at or rostral to the level of renal hilum. On multivariate analysis, total operative time correlated with body mass index in the LT approach and thickness of the perinephric fat and the distance between the adrenal tumor and the upper pole of kidney in the PR approach.
CONCLUSION: In this study, we have described an objective algorithm that can be used to select patients with unilateral adrenal tumors <6 cm for a laparoscopic PR or LT approach with favorable perioperative outcomes.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22261293     DOI: 10.1016/j.surg.2011.12.010

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  9 in total

1.  Factors affecting the surgical approach and timing of bilateral adrenalectomy.

Authors:  Billy Y Lan; Halit E Taskin; Erol Aksoy; Onur Birsen; Cem Dural; Jamie Mitchell; Allan Siperstein; Eren Berber
Journal:  Surg Endosc       Date:  2014-11-01       Impact factor: 4.584

2.  Robotic Posterior Retroperitoneal Adrenalectomy: Patient Selection and Long-Term Outcomes.

Authors:  Mehmet Gokceimam; Bora Kahramangil; Serkan Akbulut; Ozgun Erten; Eren Berber
Journal:  Ann Surg Oncol       Date:  2021-05-13       Impact factor: 5.344

Review 3.  Surgical management of adrenocortical tumours.

Authors:  Barbra S Miller; Gerard M Doherty
Journal:  Nat Rev Endocrinol       Date:  2014-03-18       Impact factor: 43.330

4.  Comparison of posterior retroperitoneal and transabdominal lateral approaches in robotic adrenalectomy: an analysis of 200 cases.

Authors:  Bora Kahramangil; Eren Berber
Journal:  Surg Endosc       Date:  2017-10-19       Impact factor: 4.584

5.  Laparoscopic versus robotic adrenalectomy in severely obese patients.

Authors:  Gizem Isiktas; Seyma Nazli Avci; Ozgun Erten; Onuralp Ergun; Vikram Krishnamurthy; Joyce Shin; Allan Siperstein; Eren Berber
Journal:  Surg Endosc       Date:  2022-09-19       Impact factor: 3.453

Review 6.  Surgical approach to patients with pheochromocytoma.

Authors:  Dhaval Patel
Journal:  Gland Surg       Date:  2020-02

Review 7.  Surgical approach to patients with primary aldosteronism.

Authors:  Catherine McManus; Jennifer H Kuo
Journal:  Gland Surg       Date:  2020-02

8.  The efficacy of laparoscopic transversus abdominis plane block on reducing postoperative narcotic usage in patients undergoing minimally invasive adrenalectomy.

Authors:  Ozgun Erten; Gizem Isiktas; Seyma N Avci; Eren Berber
Journal:  Surg Endosc       Date:  2022-02-02       Impact factor: 3.453

9.  Comparison of Robotic Posterior Retroperitoneal Adrenalectomy over Laparoscopic Posterior Retroperitoneal Adrenalectomy: A Single Tertiary Center Experience.

Authors:  Won Woong Kim; Yu-Mi Lee; Ki-Wook Chung; Suck Joon Hong; Tae-Yon Sung
Journal:  Int J Endocrinol       Date:  2019-12-01       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.